Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies

New entity offers U.S. partners the convenience of local presence with the advantages of international expertise Novel developability assessment and pre-formulation platform services shorten time to market and de-risk drug product development projects MARTINSRIED-MUNICH, Germany, May 29,…